Philip Morris
Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
Fields
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- MISS, MISSING PAGES
- MARG, MARGINALIA
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Site
- R529
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Author (Organization)
- Board on Environment Studies Toxicology
- Comm on Passive Smoking
- Natl Research Council
- Comm on Passive Smoking
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- mic02a00
Document Images
ENVIRONMENTAL
TOBACCO
SMOKE
-
Measuring, Exposures
and Assessing
Health Effects
Committee on Passive Smoking
Board on Environmental Studies and Tbxicology
National Research Council
1.
Ca vJ-u'" sc.. 1-
NATIONAL ACADEMY PRESS
Washington, D. C. 1986

National Academy Press 2101 Constitution Avenue, NW VVashington, DC 20418
NOTICE: The project that is the subject of this report was approved by
the Governing Boar&of the National Research Council; whose members are
drawn from the councils of the National Academy of Sciences, the National
Academy of Engineering, and the Institute of Medicine. The members
of the committee responsible for the report were chosen for their special
competences and with regard for appropriate balance.
This report has been reviewed by a group other than the authors
according to procedures approved by a Report Review Committee consisting
of members of the National Academy of Sciences, the National Academy of
Engineering, and the Institute of Medicine.
The National Research Council was established by the National Academy
of Sciences in 1916 to associate the broad community of science and'technol:
ogy with the Academy's purposes of'furthering knowledge and of advising the
federallgovernment. The Council operates in accordance with general policies
determined by the Academy under the authority of its congressional charter
of 1863,,which establishes the Academy as a private, nonprofit, self-governing
membership corporation. The Council has become the principali operating
agency of both the National Academy of Sciences and the National Academy
of Engineering in the conduct of their aervices to the government, the public,
and the scientific and engineering communities. It is administered jointly by
both Academies and the Institute of Medicine. The National Academy of
Engineering and the Institute of Medicine were established in 1964 and 1970,
respectively, under the charter of the National Academy of Sciences.
This study was prepared' under EPA Contract #68-02-4073 and De-
partment of Health and Human Services, Public Health Services Grant
#ASU000001-06-S1. The content of this publication does not necessarily
reflect the views or policies of the U.S. Environmental Protection Agency or
the Department of Health and Human Services, and an of$cial' endorsement
should not be inferred.
INTERNATIONAL STANDARD BOOK NUMBER 0-309-03730-1
LIBRARY OF CONGRESS CATALOG CARD NUMBER 86-28622
Copyright Qc 1986 by the National Academy of Sciences
No part of this book may be reproduce& by any mechanical, photographic,
or electronic process, or in the form of a phonographic recording, nor may it
be stored in a retrieval system, transmitted, or otherwise copied for public
or private usewithout written permission from the publisher, except for the
purposes of official use by the United States Government.
Printed in the United States of America
E
P

14
Cardiovascular System
f
f
The effects of active smoking on exercise tolerance, blbod
pressure, and the risk of developing cardiovascular disease have
been reviewed el§ehwere (U.S. Public Health Service, 1983)I. This
chapter discusses studies of ETS exposure to nonsmokers and
subsequent possible cardiovascular effects. The constituents that
are thought to have the greatest effect on the cardiovascular system
are carbon monoxide (CO), and nicotine. The possibility exists
that the mechanisms, as well as the magnitude of the effects,
for acute and' chronic cardiovascular effects may be different for
exposure to whole smoke and to ETS.
ACUTE CARDIOVASCULAR EFFECTS OF
ENVIRONMENTAL TOBACCO SMOKE EXPOSURE
Administration of nicotine at level similar to those induced
by active cigarette smoking is shortly followed by increases in
heart rate and' blood pressure (U.S. Public Health Service, 1983).
Platelet aggregation has been shown to be increased in in vitro
studies. CO rapidly combines with hemoglobin in the blood to
form carboxyhemoglobin (COHb), thereby leading to some degree
of tissue hypoxia. CO combines with muscle myoglobin, which is
followed by some muscle hypoxia. The level of exposure of the
nonsmoker to these cigarette smoke constituents, however, is less
than~ that' of the active smoker,, and the effects are expected to be
less.
Table 14-1 reviews some of the increases in COHb levels as
seen in both experimental and observational studies. The levels of
257

258
i
t
TAsLr 14-1 Carbon~ Monoxide and Carboxyhemogfobin Levels in
Nonsmoking Individuals
Ezperimental Studies IControlled Chambersf.
No: of No, of' Carboxyhemoglobin
CO!
Study
Cigarettes/h/10 mj Subjects
ppm" Controll Change (
Anderson and' Dalhamm. 3;1 - 4.5 0.3 0 ~
1973
i
Dahms et al-. 1981 - 10: 15-20, 0.6 +0.4
Harke, 1970 3:9 7 30 0.9 + 1.2
Huch et a1.. 1980 2:3 12 - 11.3 +0.5
Hugod'tt'al., 1978 2.5 1,0, 20 0.7 +0.9
Pimm et al., 1978' 2.4: 10 24: 0.5 +0.3 1
2.4: 10 241 0.7 +0.2
~
Polak, 1977 6,7 15 23' 2.0 +0.3
Russell et al.. 1973 15:1 12 38 1.6 + 1.0
I
Seppanen and Uitsitalo; 3.8 28 16 1.6 + 0.4 HI
1977
Srch.1967 50 - 90 2 +3
P
Observational Studies
Nonexposed: Exposed'
Study Subjects/Exposure No. of
Subjects Carboxy-
hemogfobin; % CO Ex-
pired, ppm
Q
Folian et a1.. 1982' Flight attendants/8 h 6 1.0:0.7 el
Jarvis et al:, 1983 Normal/public house 7 4.7:1016
for 2 h V1
Lightfoot, 1972 Normal submarine -:1.0
Wald et al.,,1981 Participants in health 6.6411
screening program
Jarviset al., 1984 Normal/self report 10 0.9:0!8' 5.7:5.5
Seppanen and Restaurant for 5 h
Uusitalo, 1977 (CO:2.S-15 ppm) 47 2.1:2.1
ea
Office for 8 h 15 2,3:2.3' 2
(CO:2.5 ppm)! 9i1
'Carbon monoxide (CO)'measured'as a proxy to indicate the concentration of ETS in the
chamber.
COHb commonly observed in active smokers are higher, ranging
between 4 to 6 percent, rarely greater than 12 percent (Schievel-
bein and Richter, 1984). Because exposure of the nonsmoker is
qualitatively different than exposure to smokers, a simple scaling
down of effects observed in active smokers does not appear to be
fully appropriate. Therefore, the effects of exposure to nicotine,
41
g
e
w
p
P~
erl

259
TABLE 14-Z Resting,Acute Cardiovascular Effects in Nondiseased
Humans of Exposure to Environmental Tobacco Smoke
Results
Authors Studc
Population
Conditions Measured
Variable
Before
AHer
Luguerte ef aI.,J970 40!children Room: 9 ml Heart rate 89 97
No: cig.: ti Blbodipressure 116,6' 120'72
Harke and Bleichert,
101 T'imer15 min
Room: n.g;
Heart rate
72 = 8
74I= 12
1972 1vo: cig.: 150 Blood pressure 123'8a 121/8a
Time: 20 min Skin temperature
('-`C/min)
0
0.0273
Rummellet al:. 1975 96 Room: 30 m-1 Heart rate 72 = 10 71 ± I 1
No,,cig,: 6-8 Blood pressure 1i171 117/71
Hurshman et al., 1978
8 T'ime:,20 min
Roomc n.g.
Hean rate
73
79
No: cig.: 2-b Blood pressure 107/6'' 114/b8
Time: 10 min
Pimm et al.. 1978' 101males Room: 14.b ml Hean rate 8a(F) 80(iF)
10 females No. cig:,: 7 77(M V 70tW
Age = 22.3 Time: 2 h
CO, or ETS need to be separately studied. In addition, consid-
eration needs to be given to persons of different sensit'ivity' or
vulnerability.
Healthy Subjects
Table 14-2 lists studies that report on the consequences of
exposure of nondiseased individuals to ETS for periods up to
2 hours under experimental~ resting conditions: There were no
significant changes noted in heart rate or blood pressure inl school-
age& children or in adult men and women.
Two studies evaluated the physiologic responses to exercise
with and without exposure to ETS. In the first, Pimm et al.
(197$) (see also Table 1'4-2) had subjects perform a 7-minute pro-
gressive exercise test! on an electronic bicycle ergometer. During
exercise, the women had higher heart rates after exposure to ETS
when compared with control conditions (differences ofl 6.3 beats
per minute at 2 minutes and 4.5 beats per minute at 7 minutes,
p< 0.01). The recovery heart rates were not significantly differ-
ent. The men, however, showed little difference between test and

260
control conditions (differences of -0.1 beats per minute at'~ 2 min-
utes and 1.5 beats per minute at 7 minutes). In the second study,
Sheppard and colleagues (1979b) tested 11 males and 12 females
at two different levels of ETS (i.e., 7 cigarettes over 2 hours, CO =
20 ppm, or 9 cigarettes over 2 hours, CO = 31 ppm). Under both
exposure conditions, contrary to expectations, both the increment
in heart rate and average heart rate were less:with ETS exposure.
In summary, for normaL young adult males and females, no
significant acute effects of ETS exposure on heart rate or bloo&
pressure have been reported, either under resting or aerobic con-
ditions.
There have been several studies of exposure of normal sub-
jects under resting and'aerobic conditions to low levels of CO but
higher than those found with ETS exposure (reviewed in Envi,
ronmental Protection Agency, 1984). No significant effects were
found in healthy, exercising subjects during short-te= exposure
(e.g., Drinkwater et al., 1974; Raven et al., 1974a,b; DeLucia et
al., 1983).
Angina Patients
Angina pectoris is a symptom complex involving feelings of
pressure and pain in the chest; which is produced by mild exercise
or excitement, presumably because of insufficient oxygen supply
to the heart muscle. Under conditions of ETS exposure, the CO
Ievels are increased, thus possibly placing individuals with angina
at an: increased risk of recurrent episodes.
Anderson et al. (1973) and Aronow and his colleagues, in a
series of experiments (1973,,1974, 1978, 1981) (Table 14-3), stud-
ied angina patients under aerobic conditions with~ exposures to lbw
levels of CO and to ETS. Ten~ patients with diagnosed angina pec-
toris, of whom two were smokers and eight exsmokers,,were tested
(Aronow et al., 1978). Significant increases in systolic blood pres-
sure and heart rate, and decreases in time to onset of angina, were
noted when the subjects were exposed to smoke in either venti-
lated or unventilated rooms (the actual levels of CO under these
conditions were not noted). There were some subjective elements
in the evaluation of these patient's, and the physician conducting,
these tests was aware of the test condi'tions,, i.e., smoking or not
and ventilated or not. Consequentlythe findings of this study, in
N
A

TABLE 14-3 Acute Cardiovascular Effects of Exposure to CO or
Environmental Tobacco Smoke by Nonsmoking Angina Patients
f
1
Study
Design No. Conditions Results
Anderson eual., Double-blind. 10" CO:50 ppm Mean duration before onset
1973 Cross-over or 100 ppm oflpain shortened'd50 ppm
Time: 4 h and~ 100ppm):, duration
for 5 days oflpain longer (100 ppm
only)
Aronow and Isbell, Double blind. 10" CO: 50 ppm Times until onset decreased;
1973 Cross-over Time:,2 h dettease in BP and heart
rate at angina
Aronow, 1978 Not blinded 10' No. cig:: 15 Earlier onset of angina: in-
Time: 2 h ereased sstolic BP and
Room: 30.28 m3 heart rate at angina
Aronow et al., 1979 Double-blind, 20 COHb: 4% Impairment in visualization
Cross-over test
Aronow, 1981 Double-blind. 1,5 CO: 50 ppm Time until onset decreased;
Cross-over Time: I It decreased systolic BP and
COHb: 2% heart rate at angina
"Includes five smokers and'five nonsmokers.
hNot current smokers.
`lneludes eight exsmokers andtwo eurrenrsmokers.
the absence of a true double-blind approach, require verification
by other research workers.
The effects of rapid angina onset would be expected to be due
to increased: COHb levels. And'erson~ et al. (1973)' and Aronow et
al. (1973y 1981), exposed angina patients to low levels of CO. In
these studies, angina pain appeared'when COHb levels of patients
were measured' at 2 and 4%. These studies have been reviewed ex-
tensiveNy as part of the Environmental Protection Agency's (1984)
activity in establishing air quality criteria for carbon monoxide.
The review group found that the results were suggestive for ef-
fects at COHb levels above 3%, based on animal and theoretical
models. There is concern t'hat elevated levels of CO exposure may
affect the electrical stability of the heart in previously compro-
mised heart muscle, thus possibly leading to sudden death, The
levels reviewed in~ Table 14-1 are close to the 3% levell This sug-
gests that there is reason to be concerned with possible effects
of exposure. However, a firm quantitative estimate of the risk to
nonsmoking persons, under conditions of ETS exposure, cannot
be made from the literature at this time.

262'
CARDIOVASCULAR DISEASE
MORBIDITY AND MORTALITY
Possible pathophysiologic mechanisms for the atherogenic in-
fluence of cigarette smoking were reviewed' in the 1983 Report of
the Surgeon General. Experimental studies of subcutaneous or
intravenous administration of nicotine in rabbits (Schievelbein~ et
al., 1970; Schievelbein and Richter, 1984) and monkeys (Liu et
al., 1979) have demonstrated that long-term exposure leads to ar-
teriosclerotic lesions. Exposure to carbon monoxide also leads to
atherosclerosis in rabbits, pigeons,,and other animals (Astrup and
Kjeldsen, 1979). Studies of whole tobacco smoke indicate that to-
tal serum cholesterol concentrations are increased and the ratios of
the various lipoprotein fractions are changed (McGill, 1979). The
contribution of whole tobacco smoke to modifying the lipoprotein
fractions is not conclusive. However, there have not been experi-
mental studies of the effects of ETS exposure or administration of
ETS extracts.
Smoking and Cardiovascular Disease
The effects of active smoking on human health are summa-
rized in the Surgeon General's report The Health Consequences
of Smoking: Cardiovascular Disease (',U.S. Public Health Service,
1983). The principal conclusions are that cigarette smokers ex-
perience a 70% greater coronary heart disease (CHD)~ death rate
than do nonsmokers and that smokers of more than two packs per
day have 2 to 3 times greater CHD death rates than nonsmokers.
The incidence of CHD in smokers is twice that of nonsmokers.
Heavy smokers (more than~ two packs per day) have an almost
fourfold increase. The relative risk in smokers for sudden death~
is greater than that for all deaths from CHD. The relative risk in~
young smokers is greater than that in older smokers. The rela-
tive risk for young women smokers, especially those who use oral
contraceptives, is greater than 5.
The excess relative risk associated with smoking declines
rapidly upon cessation of smoking, in some studies as much as
50% in 1 year. For exsmokers who previously smoked more than
one pack per day, the residual excess risk also declines, but never
completely disappears. The decline in risk on cessation of smoking
cannot be explained by differences in known cardiac risk factors
sto
of l
wei

263
between individuals who continue smoking and individuals who
have quit. Smokers who have used only pipes or cigars did not
appear to experience a substantially greater CHD risk than non-
smokers.
The rapid'. decline in risk associated with smoking cessation
and the greater relative risk for sudden death suggest that active
smoking can precipitate cardiac events in, individuals with preex-
isting coronary artery disease. Autopsy evidence of increased arte-
riosclerosis in smokers, coupled with the fact that'risk of exsmok-
ers never returns to the levels found in nonsmokers, suggests that
cigarette smoking is also implicated in the development of arte-
riosclerotic cardiovascular disease (ASCVD). The mechanism by
which cigarette smoke may lead to the development of chronic
ASCVD, sudden death, or acute myocardial infarction is unknown.
There appears, however, to be no threshold in the number of
cigarettes smoked below which there is no increase in risk.
Data on uptake of cotinine by nonsmokers exposed to ETS
indicate that the exposure in~ nonsmokers chronically exposed to
ETS is approximateUy 1% that of an active smoker (who smokes
one pack per day) (see Chapters 8 and 12). If the excess relative
risk for CHD mortality or morbidity is a linear, nonthreshold
function of dose and!, further, if the excess risk of CHD in a one-
pack-a-day smoker is twofold, then the relative risk from CHD
in nonsmokers expose& to ETS (compared to true nonsmokers)i
would be approximately 1.02. Such relative risks would be difficult
to detect or estimate reliably in nonexperimental studies. Such~
smallincreases in relative risk are of the same order of magnitude
as what might arise from expected residual confounding due to
unmeasured covariates. Nonetheless, because of the large number
of cardiovascular deaths each year, these possibilities deserve close
attention and further study that could lead to firmer estimates of
excess risk.
Studies of Environmental Tobacco Smoke Exposure and
Mortality from Cardiovascular Disease
Garland et al. (1985) have reported that, in a prospective
study of the effect of passive smoking, the age-adjusted rates
of cardiac disease deaths in nonsmoking women whose husbands
were former or current smokers were significantly elevated. It is
c

264
Y
not certain, however,,that the report is correct, because of a possi-
ble miscalculation or misuse of the Mantel-Haenszel statistic and
some other methodologic problems. Data for the wives of' former
smokers were grouped with wives:of current smokers. If this group-
ing were made after examining the d'atawhich indicated that the
risk was greater among the women whose husbands were former
smokers, then this combination would be suspect. The p values
based on the Mantel-Haenszel test may be inappropriate in view
of the small sample sizes. The authors employ the Cox Propor-
tional Hazard analysis to control for other factors associated with
cardiovascular risk, such as age, blood pressure, cholesterol, obe-
sity, years of marriage,,etc. They report a relative risk for women
married to current or former smokers compared withl women mar-
ried to never-smokers of 2.7 (Garland, 1985, corrected from an
earlier report)L The p value (< 0.10)' associated with this esti-
mate is based on the asymptotic assumptions that are implicit in
likelihood-based inference from~ the Cox model. These assump-
tions may not hold for small sample sizes. In summary, because of
the small sample sizes, the significance caltulat'ions ariaing from
this study must be looked upon as approximations.
Gillis et al. (1984) reported the results of a follow-up study
of residents of two urban communities in Scot'land. Nonsmokers
exposed to cigarette smoke in their homes had a slightly higher rate
of myocardial infarction than those unexposed. The sample size
was small, so that few of the results were statistically significant,
and other risk factors for myocardial infarction were not controlled
for.
Hirayama (1984) reported the results of a 15-year prospective
study of nonsmoking Japanese women classified at start of follow-
up by the smoking status of their husbands. A relative risk from
ischemic heart disease of 1.3 was found for nonsmoking women
whose husbands smoked more than 19 cigarettes per day com-
pared with nonsmoking women whose husbands did not smoke. A
Mantel-Haenszel test for a linear trend was significant at the p <
0.01 level.
It is unlikely that Hirayama's results can be explained by
chance. The pot!ential biases inherent in this study (see Chapter
12) limit the weight that can be placed on these results. The
observed relative risk of 1.3 is at the upper limit of the expec-
tations derived' from extrapolations from active smokers, unless
the uptake of the active component of cigarette smoke to which
H
